ℹ️
🇬🇧
Search
Search for people relevant for "Subgroup analysis"
Subgroup analysis
Person
Class
Person
Publication
Programmes
MUDr. Petra Obrtlíková Ph.D.
Academic staff at First Faculty of Medicine
39 publications
Publications
publication
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial
2019 |
Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab
2019 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
2017 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
2016 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA
2016 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Léčebné postupy v hematologii
2016 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Significantly higher numbers of proB cells in healthy Caucasians compared to Asians: Is there association with incidence of CLL?
2016 |
First Faculty of Medicine
publication
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study
2015 |
Faculty of Medicine in Hradec Králové
publication
Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015
2015 |
First Faculty of Medicine
publication
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
2015 |
Publication without faculty affiliation
Load more publications (29)
Loading network view...